NovaPeptide Review

Finnrick, an independent testing programme, publishes 4 assays for NovaPeptide, and all 4 that it grades met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation). Most recent assay 28 Apr 2026.

NovaPeptide listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/novapeptide.

NovaPeptide is listed as active.

Finnrick assay record for NovaPeptide

ProductAssaysResult
Retatrutide44 passed, 0 failed

Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.

The record for NovaPeptide

StatusActive
Vendor typeResearch-use supplier

What we found

Ordering and payment

Card payments
Not accepted
Cryptocurrency
Not accepted
Online checkout
Not available

Returns and guarantees

Research-use notice
Published on the site

Contact channels

Contact page
https://novapeptide.co/contact

How we checked

These details were read from NovaPeptide's own website on 2026-08-10. Pages consulted:

Frequently asked questions

Is NovaPeptide legit?

NovaPeptide is listed as active and we hold 4 Finnrick assays (4 passing, 0 failing its purity threshold). That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.

Has NovaPeptide been lab tested?

Yes. Finnrick, an independent testing programme, publishes 4 assays for NovaPeptide, and all 4 that it grades met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation). Most recent assay 28 Apr 2026.

Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.

Other reviewed vendors: Novo Pept Review, NOX Peptides Review, NuLife Peptides Review.